vs
FLOWERS FOODS INC（FLO）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
FLOWERS FOODS INC的季度营收约是Revvity的1.6倍（$1.2B vs $772.1M），FLOWERS FOODS INC同比增速更快（11.0% vs 5.9%），过去两年Revvity的营收复合增速更高（9.0% vs -11.6%）
花氏食品总部位于美国佐治亚州托马斯维尔，是美国知名的包装烘焙食品生产商与销售商。公司在全美19个州运营44家面包工厂，生产面包、餐包、小食蛋糕、点心、玉米饼等多元化产品，截至2013年2月已成长为美国第二大烘焙企业。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
FLO vs RVTY — 直观对比
营收规模更大
FLO
是对方的1.6倍
$772.1M
营收增速更快
FLO
高出5.1%
5.9%
两年增速更快
RVTY
近两年复合增速
-11.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $772.1M |
| 净利润 | — | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | — | 14.5% |
| 净利率 | — | 12.7% |
| 营收同比 | 11.0% | 5.9% |
| 净利润同比 | — | 3.9% |
| 每股收益（稀释后） | — | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FLORVTY
| Q4 25 | $1.2B | $772.1M | ||
| Q3 25 | $1.2B | $698.9M | ||
| Q2 25 | $1.6B | $720.3M | ||
| Q1 25 | — | $664.8M | ||
| Q4 24 | $1.2B | $729.4M | ||
| Q3 24 | $1.2B | $684.0M | ||
| Q2 24 | $1.6B | $691.7M | ||
| Q1 24 | — | $649.9M |
净利润FLORVTY
| Q4 25 | $39.5M | $98.4M | ||
| Q3 25 | $58.4M | $46.7M | ||
| Q2 25 | $53.0M | $53.9M | ||
| Q1 25 | — | $42.2M | ||
| Q4 24 | $65.0M | $94.6M | ||
| Q3 24 | $67.0M | $94.4M | ||
| Q2 24 | $73.0M | $55.4M | ||
| Q1 24 | — | $26.0M |
毛利率FLORVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率FLORVTY
| Q4 25 | 5.4% | 14.5% | ||
| Q3 25 | 7.5% | 11.7% | ||
| Q2 25 | 5.5% | 12.6% | ||
| Q1 25 | — | 10.9% | ||
| Q4 24 | 7.6% | 16.3% | ||
| Q3 24 | 7.8% | 14.3% | ||
| Q2 24 | 6.4% | 12.4% | ||
| Q1 24 | — | 6.8% |
净利率FLORVTY
| Q4 25 | 3.2% | 12.7% | ||
| Q3 25 | 4.7% | 6.7% | ||
| Q2 25 | 3.4% | 7.5% | ||
| Q1 25 | — | 6.4% | ||
| Q4 24 | 5.5% | 13.0% | ||
| Q3 24 | 5.5% | 13.8% | ||
| Q2 24 | 4.6% | 8.0% | ||
| Q1 24 | — | 4.0% |
每股收益（稀释后）FLORVTY
| Q4 25 | $0.19 | $0.86 | ||
| Q3 25 | $0.28 | $0.40 | ||
| Q2 25 | $0.25 | $0.46 | ||
| Q1 25 | — | $0.35 | ||
| Q4 24 | $0.31 | $0.77 | ||
| Q3 24 | $0.32 | $0.77 | ||
| Q2 24 | $0.34 | $0.45 | ||
| Q1 24 | — | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.1M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $7.3B |
| 总资产 | $4.2B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FLORVTY
| Q4 25 | $16.7M | $919.9M | ||
| Q3 25 | $11.0M | $931.4M | ||
| Q2 25 | $7.3M | $991.8M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $15.0M | $1.2B | ||
| Q3 24 | $6.9M | $1.2B | ||
| Q2 24 | $15.8M | $2.0B | ||
| Q1 24 | — | $1.7B |
总债务FLORVTY
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | — | — |
股东权益FLORVTY
| Q4 25 | $1.4B | $7.3B | ||
| Q3 25 | $1.4B | $7.4B | ||
| Q2 25 | $1.4B | $7.6B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $1.4B | $7.7B | ||
| Q3 24 | $1.4B | $7.9B | ||
| Q2 24 | $1.4B | $7.9B | ||
| Q1 24 | — | $7.8B |
总资产FLORVTY
| Q4 25 | $4.3B | $12.2B | ||
| Q3 25 | $4.3B | $12.1B | ||
| Q2 25 | $4.3B | $12.4B | ||
| Q1 25 | — | $12.4B | ||
| Q4 24 | $3.4B | $12.4B | ||
| Q3 24 | $3.4B | $12.8B | ||
| Q2 24 | $3.4B | $13.4B | ||
| Q1 24 | — | $13.4B |
负债/权益比FLORVTY
| Q4 25 | 1.25× | — | ||
| Q3 25 | 1.23× | — | ||
| Q2 25 | 1.26× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.75× | — | ||
| Q3 24 | 0.77× | — | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.4M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流FLORVTY
| Q4 25 | $54.4M | $182.0M | ||
| Q3 25 | $130.8M | $138.5M | ||
| Q2 25 | $135.6M | $134.3M | ||
| Q1 25 | — | $128.2M | ||
| Q4 24 | $113.9M | $174.2M | ||
| Q3 24 | $63.3M | $147.9M | ||
| Q2 24 | $105.1M | $158.6M | ||
| Q1 24 | — | $147.6M |
自由现金流FLORVTY
| Q4 25 | $30.4M | $161.8M | ||
| Q3 25 | $100.0M | $120.0M | ||
| Q2 25 | $110.1M | $115.5M | ||
| Q1 25 | — | $112.2M | ||
| Q4 24 | $88.6M | $149.8M | ||
| Q3 24 | $35.4M | $125.6M | ||
| Q2 24 | $71.8M | $136.6M | ||
| Q1 24 | — | $129.7M |
自由现金流率FLORVTY
| Q4 25 | 2.5% | 21.0% | ||
| Q3 25 | 8.0% | 17.2% | ||
| Q2 25 | 7.1% | 16.0% | ||
| Q1 25 | — | 16.9% | ||
| Q4 24 | 7.4% | 20.5% | ||
| Q3 24 | 2.9% | 18.4% | ||
| Q2 24 | 4.6% | 19.7% | ||
| Q1 24 | — | 20.0% |
资本支出强度FLORVTY
| Q4 25 | 2.0% | 2.6% | ||
| Q3 25 | 2.5% | 2.6% | ||
| Q2 25 | 1.6% | 2.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | 2.1% | 3.4% | ||
| Q3 24 | 2.3% | 3.3% | ||
| Q2 24 | 2.1% | 3.2% | ||
| Q1 24 | — | 2.7% |
现金转化率FLORVTY
| Q4 25 | 1.38× | 1.85× | ||
| Q3 25 | 2.24× | 2.97× | ||
| Q2 25 | 2.56× | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | 1.75× | 1.84× | ||
| Q3 24 | 0.94× | 1.57× | ||
| Q2 24 | 1.44× | 2.87× | ||
| Q1 24 | — | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FLO
暂无分部数据
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
